Amarin Corp Plc (AMRN)

[retinadoc]

CBB, the fact of the matter is retail ownership is somewhat meaningless in Sarissa's overall strategy. Denner played this perfectly, he waited until tax selling depressed the price, and now we are seeing institutional money pushing up the SP and accumulating shares. He had his soldiers prepped for the proxy war which he would not have initiated if he was not near certain he would win. I was amused that he dropped the hammer at JPM when the entire biotech investment community is fully tuned in.

At this point we are spectators, and Amarin's SP is in Sarissa's hands. Positive Mitigate results will certainly be helpful, but Amarin has nasty way of squandering great clinical data. Years of mineral oil idiocy has created so much FUD in cardiology that nobody actually prescribes the drug. Pfizer would have crushed Nissen/Krumholz long ago.

To see the alternative universe just look north to Canada. Rather than do some version of the HLS/Pfizer deal Amarin's management has allowed the drug to wither on the vine in the US. Karim said US sales have stabilized. Not true, especially with major insurance Co's dropping Vascepa coverage. The silent settlement with HN appears to be useless so far.

Amarin's management and BOD deserves the red wedding that Sarissa has waiting for them.